Better Therapeutics, Inc.
BTTX · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $14 | $34 | $17 | $26 |
| - Cash | $7 | $6 | $6 | $16 |
| + Debt | $14 | $14 | $15 | $15 |
| Enterprise Value | $22 | $42 | $25 | $25 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1 | -$1 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$5 | -$6 | -$8 | -$8 |
| % Margin | – | – | – | – |
| Net Income | -$6 | -$8 | -$9 | -$9 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.15 | -0.24 | -0.39 | -0.37 |
| % Growth | 37.5% | 38.5% | -5.4% | – |
| Operating Cash Flow | -$6 | -$5 | -$9 | -$6 |
| Capital Expenditures | -$0 | -$1 | -$1 | -$0 |
| Free Cash Flow | -$6 | -$6 | -$9 | -$7 |